Search results
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
Morningstar· 12 hours agoViltolarsen was approved by the United States (US) Food and Drug Administration (FDA) in 2020 under the brand name VILTEPSO® – for the treatment of Duchenne muscular ...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 4 days agoFollowing the decision, the EC has returned the opinion to the CHMP for re-evaluation. Thus, in the...
The Petri Dish: Dyne’s public offering, Kronos’ new CFO - Boston Business Journal
The Business Journals· 4 days agoAt the start of this week, Waltham’s Dyne Therapeutics Inc. had positive news to share on two...
Becker muscular dystrophy age of onset: Research and more
Medical News Today· 5 days agoBMD is a type of recessive muscular dystrophy that usually affects male children. It occurs due to a...
Up 165% This Year, Will Dyne Therapeutics Continue Its Stellar Run?
Forbes· 6 days agoThis move came in after the company released a positive clinical trial data for its experimental...
Muscular dystrophy prevention, outlook, and slowing progression
Medical News Today· 4 days agoA person may inherit the genetic changes responsible for muscular dystrophy. Muscular dystrophies...
Grandmother earns honorary degree after helping grandson graduate from UCO
KOKH FOX 25· 5 days agoA grandmother in Edmond now has an honorary degree from the University of Central Oklahoma (UCO)....
Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies
Zacks· 7 days agoDyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage studies evaluating DYNE-101 and DYNE-251 for different muscle disease indications.
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WKBN 27 Youngstown· 6 days agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced ...
Cystic fibrosis: global clinical trials landscape and treatments
Pharmaceutical Technology via Yahoo Finance· 4 days agoAffecting more than 162,000 patients worldwide, cystic fibrosis affects respiratory health and...